Table 2. Response.
Efficacy-Evaluable Populationa (n = 29) | |
---|---|
Response, n (%)b | |
CR | 0 (0) |
PR | 1 (3.4) |
SD | 6 (20.7) |
PD | 20 (69.0) |
NE | 2 (6.9) |
ORR, % (95% CI)c | 3.4 (0, 17.8) |
DCR, % (95% CI) d | 24.1 (10.3, 24.5) |
Median PFS, months (95% CI) | 2.0 (1.8, 2.1) |
CI, confidence interval; CR, complete response; DCR, disease control rate; NE, not evaluable; ORR, overall response rate. PD, progressive disease; PFS, progression-free survival; PR, partial response; SD, stable disease.
aAll enrolled patients who had at least one post-baseline tumor assessment.
bBest overall responses were identical with or without response confirmation.
cORR = (CR + PR)/total × 100.
dDCR = (CR + PR + SD)/total × 100.